Calgary-based company trying to sell collection of 2,600 wells in northwestern Alberta. If successful, it will redeploy money ...

The share price of natural gas giant Tourmaline Oil Corp. struggled for the first seven months of the year, but it has been ...

The subdued market reaction suggests that Tourmaline Oil Corp.'s (TSE:TOU) recent earnings didn't contain any surprises. Our analysis suggests that along with soft profit numbers, investors should be ...

Novartis AG is acquiring Tourmaline Bio, Inc. for $1.4B, recognizing the value of TRML's phase 3-ready IL-6 inhibitor, pacibekitug, for cardiovascular diseases. Pacibekitug demonstrated robust, ...

The NCIB allows Tourmaline to purchase up to 19,342,343 common shares (representing 5% of its issued and outstanding common shares as of July 31, 2025) over a period of twelve months commencing on ...

Tourmaline will host a conference call tomorrow, May 8, 2025, starting at 9:00 a.m. MT (11:00 a.m. ET). To participate without operator assistance, you may register and enter your phone number at ...

CRYSTALS are sources of power and may help provide a sense of balance and relief to those who believe. The Tourmaline is a gemstone that comes with a wide variety of ...

瑞士制药巨头诺华制药(NVS.US)周二表示，将以每股48美元的价格收购美国生物制药公司Tourmaline Bio(TRML.US)。这笔交易对Tourmaline Bio的估值为14亿美元。受此消息影响，Tourmaline Bio周二美股收涨近13%。 诺华制药在声明中表示，Tourmaline Bio专注于开发pacibekitug，这是一种 ...

Tourmaline Bio, Inc. announced its first quarter 2025 financial results, highlighting its ongoing Phase 2 TRANQUILITY trial which is set to reveal topline data in the second quarter of 2025. The trial ...